Gracell Biotechnologies (GRCL) Price/Book Ratio

Price: $10.25
Market Cap: $989.87M
Avg Volume: 1.46M
Country: CN
Industry: Biotechnology
Sector: Healthcare
Beta: -0.345
52W Range: $1.4-10.435
Website: Gracell Biotechnologies

What is Gracell Biotechnologies's Price/Book Ratio?

  • Gracell Biotechnologies's trailing twelve month (TTM) Price/Book ratio is 3.85.
  • Gracell Biotechnologies's annual Price/Book ratio as of today is 1.24.
  • Gracell Biotechnologies's quarterly Price/Book ratio is 1.09.

What is the Price/Book Ratio?

The Price/Book (P/B) ratio is a financial metric that compares a company's market value to its book value. It is calculated by dividing the company's stock price by its book value per share. A lower P/B ratio may indicate that the stock is undervalued.

How is the Price/Book Ratio Calculated?

P/B Ratio = (Market Price per Share) / (Book Value per Share)

Related Metrics

Other important metrics to assess Gracell Biotechnologies's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -2.81
    • Quarterly: -6.52
    • TTM: -29.10
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 0.00
    • Quarterly: 0.00
    • TTM: 0.00
  • P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -3.53
    • Quarterly: 0.00
    • TTM: 0.00
  • PEG Ratio (Price/Earnings to Growth Ratio) - measures the ratio of the P/E ratio to the company's expected earnings growth rate:
    • Annual: 0.14
    • Quarterly: 0.10
    • TTM: -0.29

These metrics provide insights into Gracell Biotechnologies's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Price/Book Ratio

1.24

Quarterly Price/Book Ratio

1.09

TTM Price/Book Ratio

3.85

Gracell Biotechnologies Historical Price/Book Ratio
1600.001600.001200.001200.00800.00800.00400.00400.000.000.00Price/Book Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical P/E Ratio
0.000.00-10.00-10.00-20.00-20.00-30.00-30.00-40.00-40.00-50.00-50.00-60.00-60.00P/E Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical P/S Ratio
8000.008000.006000.006000.004000.004000.002000.002000.000.000.00P/S Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical P/C Ratio
0.000.00-10.00-10.00-20.00-20.00-30.00-30.00-40.00-40.00-50.00-50.00-60.00-60.00P/C Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical PEG Ratio
1.421.420.870.870.330.33-0.22-0.22PEG Ratio20192019Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023

Gracell Biotechnologies Historical Ratios

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2022.

Year Price/Book Ratio P/E Ratio P/S Ratio P/C Ratio PEG Ratio
2022 1.24 -2.81 0.00 -3.53 0.14
2021 1.38 -5.42 6894.82 -8.29 -0.04
2020 13.08 -54.38 0.00 -54.10 0.99
2019 13.53 -26.15 0.00 -25.52 -0.22
2018 1432.24 -56.14 0.00 -55.18 0.00

Related Metrics

Explore detailed financial metrics and analysis for GRCL.